High Tower Advisors, LLC Alaunos Therapeutics, Inc. Transaction History

High Tower Advisors, LLC

$64.2 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.43 - $0.65 $6,450 - $9,750	15,001 Added 37.43%	55,075 $28,000
Q4 2022 Feb 08, 2023	SELL	$0.5 - $261.0 $100 - $52,461	-201 Reduced 0.5%	40,074 $26,000
Q2 2022 Aug 10, 2022	SELL	$0.41 - $1.24 $1,025 - $3,100	-2,500 Reduced 5.84%	40,275 $51,000
Q4 2021 Feb 10, 2022	SELL	$1.09 - $1.89 $9,919 - $17,199	-9,100 Reduced 17.54%	42,775 $46,000
Q3 2021 Nov 12, 2021	BUY	$1.44 - $2.73 $552 - $1,048	384 Added 0.75%	51,875 $95,000
Q2 2021 Aug 06, 2021	SELL	$2.63 - $3.67 $19,725 - $27,525	-7,500 Reduced 12.71%	51,491 $136,000
Q1 2021 May 10, 2021	BUY	$2.82 - $5.6 $166,354 - $330,349	58,991 New	58,991 $213,000
Q4 2020 Feb 10, 2021	SELL	$2.09 - $3.09 $104,272 - $154,163	-49,891 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$2.39 - $3.43 $118,962 - $170,728	-49,775 Reduced 49.94%	49,891 $125,000
Q2 2020 Aug 10, 2020	SELL	$2.2 - $3.71 $69,537 - $117,265	-31,608 Reduced 24.08%	99,666 $328,000
Q1 2020 May 21, 2020	SELL	$1.9 - $4.98 $7,220 - $18,924	-3,800 Reduced 2.81%	131,274 $322,000
Q4 2019 Feb 14, 2020	SELL	$3.95 - $5.35 $64,886 - $87,884	-16,427 Reduced 10.84%	135,074 $636,000
Q3 2019 Nov 12, 2019	BUY	$4.13 - $6.94 $38,512 - $64,715	9,325 Added 6.56%	151,501 $648,000
Q2 2019 Aug 13, 2019	SELL	$3.98 - $6.2 $50,944 - $79,360	-12,800 Reduced 8.26%	142,176 $827,000
Q1 2019 May 15, 2019	BUY	$2.0 - $4.4 $96,792 - $212,942	48,396 Added 45.41%	154,976 $595,000
Q4 2018 Feb 14, 2019	BUY	$1.61 - $3.62 $1,455 - $3,272	904 Added 0.86%	106,580 $198,000
Q3 2018 Nov 09, 2018	BUY	$2.26 - $3.27 $10,847 - $15,696	4,800 Added 4.76%	105,676 $337,000
Q2 2018 Aug 14, 2018	SELL	$3.02 - $4.94 $23,254 - $38,038	-7,700 Reduced 7.09%	100,876 $306,000
Q1 2018 May 15, 2018	BUY	$3.46 - $5.14 $102,416 - $152,144	29,600 Added 37.48%	108,576 $427,000
Q4 2017 Feb 14, 2018	BUY	$4.0 - $6.54 $131,416 - $214,865	32,854 Added 71.23%	78,976 $326,000
Q3 2017 Nov 14, 2017	SELL	$4.99 - $6.57 $10,918 - $14,375	-2,188 Reduced 4.53%	46,122 $282,000
Q2 2017 Aug 14, 2017	BUY	N/A	48,310	48,310 $300,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account